TOVX

Theriva Biologics, Inc. TOVX

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode TOVX KTTA CNSP OGEN SNGX GRI NLSP JAGX CANF ENSC
6M -67.85 % -48.88 % -14.74 % -77.05 % -20.29 % 32.88 % 13.79 % -63.06 % -59.60 % 43.37 %
YTD -74.48 % -75.05 % -86.89 % -88.33 % -43.88 % -86.57 % -24.31 % -92.37 % -72.01 % -71.15 %
1Y -71.74 % -83.08 % -87.43 % -87.12 % -57.36 % -80.32 % -68.87 % -93.18 % -82.54 % -10.86 %
3Y -98.25 % -96.59 % -99.99 % -99.69 % -98.99 % -99.99 % -91.75 % -99.96 % -93.40 % -99.72 %
5Y -99.48 % -98.97 % -100.00 % -99.88 % -99.60 % -100.00 % -98.57 % -99.99 % -97.26 % -99.99 %
10Y -100.00 % -98.97 % -100.00 % -100.00 % -99.94 % -100.00 % -98.57 % -100.00 % -99.92 % -99.99 %
From the beginning -100.00 % -98.97 % -100.00 % -100.00 % -100.00 % -100.00 % -98.57 % -100.00 % -99.94 % -99.99 %

Dividend